Hyaluronic acid (HA) is as naturally occurring glycosaminoglycan composed of repeating disaccharide units consisting of glucuronic acids and N-acetylglucosamine, resulting in different molecular weights. HA plays a crucial pathophysiological role in rheumatic diseases, especially concerning joint health and function.
1. Introduction
Hyaluronic acid (HA) plays an important role in a wide range of medical physiological and pathological conditions: Notably, it finds application in dermatology, ophthalmology, cosmetic medicine, and rheumatology
[1][2][3][1,2,3]. Its significance extends to wound healing, granulation, and cell migration
[4]. However, the efficacy of HA in rheumatology remains a subject of controversy at times
[5][6][5,6].
HA is as naturally occurring glycosaminoglycan composed of repeating disaccharide units consisting of glucuronic acids and N-acetylglucosamine (
Figure 1), resulting in different molecular weights
[7][8][9][7,8,9]. This structural variability imparts diverse functional implications in both physiological and pathological contexts
[10]. HA is commercially produced through extraction from animal tissues, such as chicken combs, and from Streptococci bacteria
[11].
Figure 1. Skeletal formula of hyaluronan—a polymer consisting of D-glucuronic acid and
N-acetyl-D-glucosamine linked via alternating β-(1→4) and β-(1→3) glycosidic bonds
[7].
Functionally, HA demonstrates remarkable water-binding capacity, rendering it an essential constituent of the extracellular matrix (ECM)
[12]. Its elongated, unbranched chains create a gel-like network, imparting hydration and lubrication to crucial tissues like the skin, cartilage, and synovial fluid
[13][14][15][13,14,15].
In the field of rheumatology, HA has garnered substantial attention, owing to its pivotal involvement in joint health and its relevance to diseases like osteoarthritis (OA) and rheumatoid arthritis (RA)
[16][17][16,17].
OA is a degenerative joint disorder characterized by the gradual deterioration of articular cartilage, resulting in pain, stiffness, and diminished joint function
[18]. There is no cure for OA, so doctors usually treat OA symptoms with a combination of therapies
[18]. HA serves as a lubricant and shock absorber within the synovial fluid, facilitating smooth joint movements
[19]. However, in OA, the concentration and quality of HA decrease, compromising its protective and viscoelastic properties due to heightened degradation and decreased synthesis. Consequently, this leads to impaired cartilage function and joint degeneration
[20]. As a therapeutic approach, supplementation with exogenous HA has emerged to alleviate symptoms and enhance joint function in OA patients
[21]. By restoring synovial fluid viscosity and promoting cartilage repair, HA aids in improving joint mobility and reducing pain
[16].
On the other hand, RA is an autoimmune and inflammatory disease characterized by the immune system mistakenly attacking healthy cells, resulting in inflammation, particularly in the joints, leading to painful swelling
[22]. RA can be effectively treated and managed with medication(s) and self-management strategies
[22]. In RA, the level of HA in the synovial fluid is significantly diminished, causing reduced lubrication and increased inflammation and pain
[23].
Numerous studies have explored the potential therapeutic benefits of exogenous HA supplementation in rheumatic diseases. Through intra-articular injections, HA has shown promise in improving joint mobility, reducing pain, and promoting cartilage repair by restoring synovial fluid viscosity
[24].
Furthermore, HA has demonstrated immunomodulatory effects, including the suppression of pro-inflammatory cytokines and the promotion of anti-inflammatory cytokine production
[25]. This suggests that HA may also hold promise in the treatment of immune-mediated rheumatic diseases
[26].
Moreover, researchers have explored HA’s potential applications in drug delivery systems and tissue engineering due to its biocompatibility and biodegradability
[27].
However, the use of HA therapy in rheumatology remains a topic of controversy, with conflicting evidence regarding its efficacy and safety
[5][28][5,28].
In summary, HA represents a promising therapeutic option in the field of rheumatology due to its potential to enhance joint function and alleviate inflammation and pain
[29]. Nevertheless, further investigation is required to fully elucidate its therapeutic potential in rheumatic diseases.
2. Hyaluronic Acid: Structure, Function, and Biochemistry
HA plays a crucial role in diverse cellular and tissue processes, encompassing hydration, lubrication, tissue repair, regulation of inflammation, and cell signaling
[14]. It is naturally synthesized by various cell types, predominantly fibroblasts, chondrocytes, and synoviocytes
[30]. The biosynthesis of HA takes place in the plasma membrane through the coordinated activity of specific enzymes, including hyaluronan synthases
[30].
2.1. Molecular Structure of Hyaluronic Acid
Hyaluronan synthases catalyze the addition of glucuronic acid and N-acetylglucosamine, leading to the formation of the repeating disaccharide units that constitute HA
[31]. The molecular weight of HA displays highly variability, ranging from several hundred kilo Da to millions of kilo Da, exerting a direct impact on its functional properties
[32]: Notably, higher-molecular-weight HA exhibits increased viscosity
[33], thereby affecting its flow and lubrication capability, i.e., in joints
[34]. As a result, high-molecular-weight HA provides superior lubrication and cushioning effects
[35].
2.2. Biosynthesis and Degradation of Hyaluronic Acid
HA turnover in tissues is intricately regulated by a delicate balance between biosynthesis and degradation processes
[36]. The degradation of HA primarily involves the action of enzymes known as hyaluronidases, which cleave HA into smaller fragments
[37]. Hyaluronidase enzymes are categorized into several families, including HYAL1, HYAL2, and PH-20
[38], and they play a pivotal role in maintaining the appropriate concentration and size distribution of HA within tissues
[39]. Furthermore, the degradation of HA can be modulated by reactive oxygen species, matrix metalloproteinases (MMPs), and other factors present in the extracellular environment
[40].
2.3. Physiological Functions and Distribution in Tissues of Hyaluronic Acid
HA plays a critical role in tissue repair and remodeling processes within the human body
[41]. It participates in various stages of wound healing, encompassing inflammation, cell migration, proliferation, and ECM remodeling
[42]. As a scaffolding molecule, HA provides essential structural support and aids in cell migration during tissue repair
[43] (
Table 1).
Table 1.
Physiological functions of hyaluronic acid (HA) in rheumatology.